Prostate Cancer

Top Story

Early dinner associated with reduced risk for prostate, breast cancer

July 17, 2018
In the Journals Plus

‘Simple’ model predicts risk for cancer-related venous thromboembolism

July 17, 2018
A clinical prediction model that used tumor-site category and D-dimer as the only variables accurately predicted risk for venous thromboembolism among patients with…
FDA News

FDA expands Xtandi approval for prostate cancer

July 16, 2018
The FDA expanded the approval of enzalutamide to include the treatment of nonmetastatic castration-resistant prostate cancer. Enzalutamide (Xtandi; Astellas, Pfizer)…

Use of conservative management for low-risk prostate cancer ‘increasing rapidly’

July 16, 2018
Conservative management or deferred treatment is the preferred approach for men with low-risk prostate cancer, according to results of a large VA cohort study. Stacy
More Headlines »
CME ABIM MOC

Ace the Case: A 55-Year-Old Woman With an Oddly-Shaped, Raised Pigmented Lesion on Right Thigh

There is no commercial support for this activity.

This “Ace the Case” activity will utilize a case-based approach in a 55-year-old woman to discuss the diagnosis and…
More »
Video
Meeting News

VIDEO: Genomic risk system may help treat prostate cancer

July 19, 2017
More »
Resource Centers
ASCO Annual Meeting

ASCO Annual Meeting

CME CNE CPE

Immune Checkpoint Inhibitors for Genitourinary Cancers: Practice Essential for Community Oncologists and Advanced Practice Providers

This activity is supported by an educational grant from Merck & Co., Inc.

For many years, the mainstay of initial treatment for metastatic bladder cancer has been chemotherapy. However…
More »